OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Linagliptin counteracts rotenone’s toxicity in non-diabetic rat model of Parkinson’s disease: Insights into the neuroprotective roles of DJ-1, SIRT-1/Nrf-2 and implications of HIF1-α
Rania Z ElGamal, Mariane G. Tadros, Esther T. Menze
European Journal of Pharmacology (2023) Vol. 941, pp. 175498-175498
Closed Access | Times Cited: 5

Showing 5 citing articles:

Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications
Paras Mani Giri, Anurag Banerjee, Arpita Ghosal, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3995-3995
Open Access | Times Cited: 28

Modulation of FOXO3a Nuclear Localization by Linagliptin (BI-1356) Reveals a New Therapeutic Target in Chronic Ulcerative Colitis
Abdulaziz Alshahrani, Sameh Saber, Ohoud Shafi Alruwaili, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107100-107100
Open Access

Linagliptin ameliorates tacrolimus-induced renal injury: role of Nrf2/HO-1 and HIF-1α/CTGF/PAI-1
M. Nady, Ola M. Abd El‐Raouf, El-Sayed M. El-Sayed
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 2

Anti-Inflammatory Effects of Dipeptidyl Peptidase-4 Inhibitors and Their Therapeutic Application for Parkinson's Disease
Yeojin Bang, Soung-Hee Moon, Sumin Lee, et al.
Drug Targets and Therapeutics (2024) Vol. 3, Iss. 1, pp. 83-93
Open Access | Times Cited: 1

Acute and Chronic Exposure to Linagliptin, a Selective Inhibitor of Dipeptidyl Peptidase-4 (DPP-4), Has an Effect on Dopamine, Serotonin and Noradrenaline Level in the Striatum and Hippocampus of Rats
Małgorzata Łupina, Agnieszka Wąsik, Irena Baranowska‐Bosiacka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3008-3008
Open Access

Crosstalk between SIRT1/Nrf2 signaling and NLRP3 inflammasome/pyroptosis as a mechanistic approach for the neuroprotective effect of linagliptin in Parkinson’s disease
Wessam Z. Ghaith, Walaa Wadie, Mohammed F. EL-Yamany
International Immunopharmacology (2024) Vol. 145, pp. 113716-113716
Closed Access

Page 1

Scroll to top